Drug-Drug Interactions Concept Map: An Overview
Generally, drugs may interact with other drugs, food, herbs, and laboratory results. This concept map focuses on drug-drug interactions types, mechanisms of interactions, preventive measures, and risk factors along with a sufficient number of examples of the most common and the most clinically significant drug-drug interactions. Here is an overview about our unique “One Picture” on Drug-drug interactions (DDIs) concept map from Zoom out – Pharmacotherapy.
The map starts with a definition of drug-drug interactions which is a situation in which a drug affects the activity of another drug when they are both administered together.
These interactions occur when the precipitant drug affects the plasma concentration of the object drug through changes in the absorption, distribution, metabolism, or excretion of the object drug.
Mechanisms of DDIs through changes in absorption
- Drug Binding
It occurs when the drug(s) bind to another in GIT. The map explains the difference between (Adsorption) and (Chelation); the two mechanisms responsible for drug binding. Drug binding doesn’t usually cause harmful interactions, as it may be useful clinically. Find out more in the map.
- Changes in Gastrointestinal Motility
These changes affect what is called Gastric Emptying Rate (GER) and consequently affect drug absorption rate and/or extent. Know from the map what GER is and which drugs increase and decrease GER and drug absorption rate. An interesting example; how pretreatment with propanthelin enhances digoxin bioavailability? Understand the mechanism as shown in the map in the form of a flowchart.
- Alteration in Gastrointestinal pH
The map lets you understand the effect of GI pH on weak acidic and weak basic drugs’ extent of absorption.
- Effect on Intestinal Flora
See the image below. It is showing part of the map that concerns intestinal flora effect on drug absorption. Two examples are provided; antibiotics co-administered with digoxin and co-administered with oral hormonal contraceptives.
- Alterations in Drug Metabolism within the Intestinal Wall
Hypertensive crisis caused by co-administration of tyramine containing food with MAO inhibitors is a clinically significant drug interaction that is shown as an example in this part of the map.
Distribution occurs after the absorbed drug enters the bloodstream. It is carried by plasma proteins to reach its site of action and exerts its pharmacological effect. Transport plasma proteins are albumin and alpha1-acid glycoprotein (AAG). Certain diseases and conditions as: liver cirrhosis, renal failure, inflammatory diseases, and pregnancy can change the serum concentrations of these plasma proteins and consequently affects drug distribution. Distribution drug-drug interactions can occur through one of the following mechanisms (explained in the map):
- Drug-induced decrease in concentration of binding protein.
Also mentioned in the map, four cases in which the clinical significance of drug displacement interactions increase.
Many administered drugs are extensively metabolized in the liver by hepatic enzymes. The most common among these enzymes are cytochrome P450 enzymes. Know about these enzymes’ nomenclature, function, and other information through this part of the map.
Cytochrome P450 drug-drug interactions can occur through:
- Enzyme Inhibition
You’ll also find a table with some examples of interacting drugs through inhibition of cytochrome P450 enzymes.
- Enzyme Induction
There is also a table with some examples of interacting drugs through inhibition of cytochrome P450 enzymes.
They are drugs that have no therapeutic action until they are metabolized into active compounds. As CYP450 enzymes have a role in the activation of prodrugs, then enzyme inhibitors and inducers can interfere with the activation of prodrugs. Know more about the possible mechanisms of inhibition or induction of CYP450 in the case of prodrugs as losartan and tramadol through this part of the map.
Excretory organs are: the biliary system, the lungs, the skin, and the kidney which plays the most important role in excretion. Excretion of drugs by the kidney involves 3 main mechanisms:
- Glomerular Filtration
In a logical way, the map explains how glomerular filtration takes place and how nephrotoxicdrugs as: cyclosporine, tacrolimus, non-steroidal anti-inflammatory drugs (NSAIDs), angiotensin-converting enzyme inhibitors (ACEIs), and angiotensin II receptor blockers (ARBs) decrease excretion of drugs eliminated by glomerular filtration resulting in accumulation of these drugs and increased toxicity.
- Active Tubular Secretion
It is an active process (requires ATP) in which the drug is carried on a certain transporter to be excreted from the body. The saturation of this process by two drugs competing for the same carrier proteins causes the accumulation of one or both of these drugs. Two examples of drug-drug interactions due to drugs competing on active tubular secretion are mentioned in the map. They include: probenecid and cimetidine.
- Passive Tubular Reabsorption
Here is a glimpse of this part as shown in the map.
They occur when a certain drug modulates the pharmacologic effect of another one without a change in its concentration. Pharmacodynamic Interactions occur due to one of these mechanisms: additivity, synergism, or antagonism.
Mechanisms of Pharmacodynamic Interactions
Detailed explanations and examples are included in the map
Risk factors of DDI
They can be classified into:
- Patient-related risk factors
Details related to the patient’s gender, diseases, and age are stated in the map.
- Drug-related risk factors
In the map, you’ll find more information about:
- Polypharmacy/ Therapeutic jungle
- Drugs with narrow therapeutic indices
- Route of drug administration
- Time-dependent drug-drug interactions
- Drugs with high first pass metabolism (FPM)
- Drugs with highly plasma protein binding
You’ve to remember that these risk factors may increase the probability and the clinical significance of drug-drug interactions. This part is followed by examples of clinically significant drug-drug interactions.
Categories/ Classification of DDIs
Classification according to Drug.com
Classification according to Lexi-comp
Tips for preventing DDIs incidence
This is the final part of the map which provides 7 general tips to prevent and reduce the incidence of drug-drug interactions. The map also contains hints on how to avoid drug interactions caused by changes in absorption, distribution, metabolism, and excretion.
Besides its content of more than 40 examples of drug-drug interactions, this two-part map of drug-drug interactions is made in a comprehensive way to make the topic easy to understand and memorize.
Order the map
You can order (Drug-drug Interactions Map) in any of the following forms according to your preference. Our maps are comprehensive in a way that can benefit both students and clinicians.
This map is available in two forms;
1. Printable version.
2. Whole map version.
Check them out below to know the difference, so that you can choose what is suitable for you. And please feel free to leave your suggestions, comments, or questions in the comments section below.